利用DNA聚合酶β缺陷增强了胃癌细胞的合成致死性和治疗反应:对免疫治疗的含义
Aashirwad Shahi1, Shengyuan Zhao2, Dawit Kidane1
1Department of Physiology and Biophysics, College of Medicine, Howard University, Washington, DC, United States.
概括
患有DNA聚合酶β (POLB) 缺陷的胃癌细胞易受PARP1抑制剂的影响,导致DNA损伤和免疫激活. 针对POLB缺陷提供了一种新的策略,以增强胃癌治疗反应和基于免疫的疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 胃癌是全球癌症死亡的主要原因之一.
- 氧化应激会导致DNA损伤,包括氧化基和单链断裂.
- 基切除修复 (BER) 对于修复氧化DNA损伤至关重要,DNA聚合酶β (Pol β) 起着关键作用.
研究的目的:
- 审查DNA聚合酶β (POLB) 在胃癌中的作用.
- 探索针对POLB缺陷的治疗潜力.
- 为了研究POLB缺乏,PARP1抑制和胃癌中的免疫反应之间的相互作用.
主要方法:
- 审查现有文献和先前发表的数据.
- 对PARP1抑制剂如何在POLB缺乏细胞中诱导DNA损伤的机制性见解.
- 对DNA介导的先天免疫信号激活的分析.
主要成果:
- 缺少POLB会在癌细胞中产生遗传负债,使得它们易受向疗法的治疗.
- PARP1 抑制剂 (Olaparib) 在缺乏 POLB 的胃癌细胞中诱导与复制相关的双链断裂.
- 这种DNA损伤触发了先天性免疫信号,可能会增强免疫疗法.
结论:
- POLB状态可以作为对胃癌患者分层的遗传指标.
- 利用POLB遗传缺陷可以提高胃癌的治疗反应.
- 用基于免疫的策略准缺乏POLB的胃癌细胞可能会产生协同效应.
更多相关视频
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019
6.0K
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
1.1K
相关概念视频
Translesion DNA Polymerases
11.1K
Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
11.1K
Bacterial RNA Polymerase
32.6K
Unlike eukaryotes, bacteria use a single RNA Polymerase (RNAP) to transcribe all genes. The different subunits of bacterial RNAPhave distinct functions. The multisubunit structure of the bacterial RNAP helps the enzyme to maintain catalytic function, facilitate assembly, interact with DNA and RNA, and self-regulate its activity.
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
32.6K
RNA Polymerase II Accessory Proteins
10.8K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
10.8K
Eukaryotic RNA Polymerases
26.8K
RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...
All three eukaryotic RNAPs require specific transcription factors, of which the...
26.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Lethal Alleles
17.7K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
17.7K
